July 24, 2018
Proteome Sciences announces its unaudited interim results for the six months ended 30 June 2018.
Commenting on these results, Jeremy Haigh, Chief Executive Officer of Proteome Sciences, said:
“Performance during the first six months of 2018 was behind expectations, with recognised revenues from our services business still lagging committed work orders as we continue to build our customer base; TMT® revenues were ahead of the equivalent period in 2017.